Robert brings 25 years of life science capital market and corporate counsel experience.He founded the Company, and has served as Chairman and Chief Executive. Prior to Aurora, Robert founded and served as Chief Executive Officer of Medvax Technologies, a clinical stage cancer immunotherapy company developing dendritic cell and peptide cancer vaccines. Robert has been corporate counsel to numerous life science companies. He has participated in over $500 million of private and public offerings of life science and growth companies in the capital markets. He received his B.S. in Biology (pre-medicine concentration) Cum Laude from the University of Massachusetts, and Juris Doctorate from the University of Miami Law School. He has held a Series 7 securities license.
Marc is the Kathleen and Stanley Glaser Professor of Medicine and Deputy Director of the University of Miami Sylvester Comprehensive Cancer Center. Previously, from February 2001 to May 2007 he served as the John G. Searle Professor and Chairman of the Department of Internal Medicine at the University of Michigan School of Medicine. Previously, Dr. Lippman was the Director of the Lombardi Cancer Research Center from July 1988 to February 2001, Professor and Chairman of the Department of Oncology from July 1999 to February 2001 and Professor of Medicine at Georgetown University Medical School in Washington, D.C. from July 1988 to February 2001. He also served as Chief of the Division of Hematology-Oncology at Georgetown University Medical School from July 1995 to February 2001. He was Head of the Medical Breast Cancer Section of the Medicine Branch of the National Cancer Institute from July 1976 to July 1988. Dr. Lippman has authored over 500 peer- reviewed publications.